Viewing Study NCT02202161


Ignite Creation Date: 2025-12-24 @ 11:52 AM
Ignite Modification Date: 2026-02-05 @ 6:22 AM
Study NCT ID: NCT02202161
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2014-07-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 201351
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators